Lowes Lori E, Goodale David, Keeney Michael, Allan Alison L
London Regional Cancer Program, London Health Sciences Centre, London, Ontario, Canada.
Methods Cell Biol. 2011;102:261-90. doi: 10.1016/B978-0-12-374912-3.00010-9.
The majority of cancer-related deaths are as a result of metastatic disease, which has been correlated with the presence of circulating tumor cells (CTCs) in the bloodstream. Therefore the ability to reliably enumerate and characterize these cells could provide useful information about the biology of the metastatic cascade; facilitate patient prognosis; act as a marker of therapeutic response; and/or aid in novel anticancer drug development. Several different techniques have been utilized for the enrichment and detection of these rare CTCs, each having their own unique advantages and disadvantages. In this chapter we will briefly discuss each of these techniques as well as the pros and cons of each approach. In particular, we will provide a comprehensive examination of two image cytometry approaches for CTC analysis that are in routine use in our laboratory; the iCys Laser Scanning Cytometer (Compucyte, Cambridge, MA), and the CellSearch® system (Veridex, North Raritan, NJ). The ability to detect, enumerate, and characterize CTCs is an important tool for the study of the metastatic cascade and the improved clinical management of cancer patients. These rare cells could shed light on the basic biology behind this highly lethal process and ultimately change current patient treatment guidelines.
大多数癌症相关死亡是由转移性疾病导致的,而转移性疾病与血液中循环肿瘤细胞(CTC)的存在相关。因此,可靠地计数和表征这些细胞的能力可为转移级联反应的生物学特性提供有用信息;有助于患者预后评估;作为治疗反应的标志物;和/或辅助新型抗癌药物的研发。已经采用了几种不同的技术来富集和检测这些罕见的CTC,每种技术都有其独特的优缺点。在本章中,我们将简要讨论每种技术以及每种方法的优缺点。特别是,我们将全面介绍我们实验室常规使用的两种用于CTC分析的图像细胞术方法;iCys激光扫描细胞仪(Compucyte公司,马萨诸塞州剑桥)和CellSearch®系统(Veridex公司,新泽西州北拉里坦)。检测、计数和表征CTC的能力是研究转移级联反应和改善癌症患者临床管理的重要工具。这些罕见细胞可以揭示这一致命过程背后的基础生物学原理,并最终改变当前的患者治疗指南。